Oxford Science Enterprises focuses on early-stage investments in transformational businesses spun out of the University of Oxford, primarily across Life Sciences, Health Tech, AI & Software, and Deep Technology sectors. Their strategy involves providing patient, long-term capital, hands-on venture building, and operational support to guide these companies from inception to global scale.
Deal activity increased 300% year-over-year (8 deals in the last 12 months). Their most common stage is series-a (42% of deals). Average disclosed round size is $36.1M (across 22 rounds with reported amounts).
Portfolio
24
Fund Size
$1.4B
Top Stage
Series A
Last 12 Mo
8
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
24 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| AAllos | Seed | $5M | Jan 2026 |
 Allos AI | Seed | $5M | Jan 2026 |
 Beacon Therapeutics | Series C | — | Jan 2026 |
| SScripta Therapeutics | Seed | $12M | Nov 2025 |
| WWild Bioscience | Series A | $51M | Oct 2025 |
 Kneu Health | Seed | $5.6M | Oct 2025 |
 Ultromics | Series C | $55M | Jul 2025 |
| MMixergy | Series A | $15.2M | Mar 2025 |
| SSalience Labs | Series A | $30M | Feb 2025 |
 OQC | Series B | $100M | Mar 2024 |
| PProlific | Series A | $31.8M | Jul 2023 |
| PProlific | Series B | $31.8M | Jul 2023 |
| PProlific | Series B | $32M | Jul 2023 |
| Beacon Therapeutics | Series D | $120M | Jun 2023 |
| CCaristo Diagnostics Limited | Series A | $16.3M | Apr 2023 |
| OOxford Ionics | Series A | $36.6M | Jan 2023 |
| BBehaVR | Series B | $13M | Dec 2022 |
 Oxford Quantum Circuits | Series A | $46M | Jul 2022 |
| Oxford Quantum Circuits | Series A | $47M | Jul 2022 |
 BibliU | Series B | $15M | Jun 2022 |
 Scenic Biotech | Series A | $31M | Mar 2022 |
 PQShield | Series A | $20M | Jan 2022 |
| OONI | Series B | $75M | Jan 2022 |
| EEvolito | Unknown | — | — |
Top Co-Investors
Lansdowne Partners4 shared
Partech3 shared
Berkeley SkyDeck2 shared
Braavos2 shared
British Patient Capital2 shared
Oxford Investment Consultants2 shared
Addition1 shared
AlbionVC1 shared
Forbion1 shared
EI Ventures1 shared
Vesalius Biocapital1 shared
INKEF Capital1 shared
BioGeneration Ventures1 shared
Chevron Technology Ventures1 shared
SBI Investment1 shared
Cambridge Innovation Capital1 shared
Silicon Catalyst Ventures1 shared
Optum Ventures1 shared
Accenture1 shared
Last updated: 5 March 2026